Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4640937
Max Phase: Preclinical
Molecular Formula: C46H64BrN8O9+
Molecular Weight: 952.97
Molecule Type: Unknown
Associated Items:
ID: ALA4640937
Max Phase: Preclinical
Molecular Formula: C46H64BrN8O9+
Molecular Weight: 952.97
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCC[N+](C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)cc1)C(N)=O
Standard InChI: InChI=1S/C46H63BrN8O9/c1-28(2)24-36(40(48)58)51-46(64)39(27-56)54-43(61)35(14-10-11-23-55(4,5)6)50-45(63)38(26-31-15-21-34(57)22-16-31)52-41(59)29(3)49-44(62)37(25-30-12-8-7-9-13-30)53-42(60)32-17-19-33(47)20-18-32/h7-9,12-13,15-22,28-29,35-39,56H,10-11,14,23-27H2,1-6H3,(H8-,48,49,50,51,52,53,54,57,58,59,60,61,62,63,64)/p+1/t29-,35-,36-,37-,38-,39-/m0/s1
Standard InChI Key: HCMMROKOKZFBSA-VUIPDPFBSA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 952.97 | Molecular Weight (Monoisotopic): 951.3974 | AlogP: 1.58 | #Rotatable Bonds: 25 |
Polar Surface Area: 258.15 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.50 | CX Basic pKa: | CX LogP: -1.89 | CX LogD: -1.61 |
Aromatic Rings: 3 | Heavy Atoms: 64 | QED Weighted: 0.04 | Np Likeness Score: 0.06 |
1. Milosevich N, McFarlane J, Gignac MC, Li J, Brown TM, Wilson CR, Devorkin L, Croft CS, Hof R, Paci I, Lum JJ, Hof F.. (2020) Pan-specific and partially selective dye-labeled peptidic inhibitors of the polycomb paralog proteins., 28 (1): [PMID:31753799] [10.1016/j.bmc.2019.115176] |
Source(1):